Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial
暂无分享,去创建一个
P. Sandercock | J. Wardlaw | R. Lindley | Joel B E Smith | E. Lundström | E. Berge | W. Whiteley | J. Forbes | Geoff Cohen | Karsten Bruins Slot | Ann-Sofie Rudberg | Melinda B Roaldsen | Eva Isaksson | J. Drever | G. Cohen | K. B. Slot
[1] Peter Sandercock,et al. The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke , 2008, Trials.
[2] R. Shinton. Questions about authorisation of alteplase for ischaemic stroke , 2014, The Lancet.
[3] Eric Manheimer,et al. Thrombolysis in acute ischaemic stroke: time for a rethink? , 2015, BMJ : British Medical Journal.
[4] Sarah Parish,et al. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. , 1988, Journal of the American College of Cardiology.
[5] Geoff Cohen,et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis , 2012, The Lancet.
[6] P. Sandercock,et al. Statistical Analysis Plan for the Third International Stroke Trial (IST-3); Part of a ‘Thread’ of Reports of the Trial , 2012, International journal of stroke : official journal of the International Stroke Society.
[7] R. Lindley,et al. Thrombolysis for acute ischaemic stroke: consumer involvement in design of new randomised controlled trial , 2002, BMJ : British Medical Journal.
[8] G. Hankey,et al. Do risks outweigh benefits in thrombolysis for stroke? , 2013, BMJ.
[9] J. Wardlaw,et al. A simple practical classification of cerebral infarcts on CT and its interobserver reliability. , 1994, AJNR. American journal of neuroradiology.
[10] Joanna M. Wardlaw,et al. Alteplase for Acute Ischemic Stroke: Outcomes by Clinically Important Subgroups in the Third International Stroke Trial , 2015, Stroke.
[11] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.,et al. EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION , 1986, The Lancet.
[12] P. Sandercock,et al. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited , 2011, Trials.
[13] P. Sandercock. Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial , 2013, The Lancet Neurology.
[14] P. Sandercock,et al. Functional Status Three Months after the First Ischemic Stroke Is Associated with Long-Term Outcome: Data from a Community-Based Cohort , 2014, Cerebrovascular Diseases.
[15] Joseph P. Broderick,et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year , 1999 .
[16] Geoff Cohen,et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial , 2012, The Lancet.
[17] P. Dorman,et al. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies , 2008, BMJ : British Medical Journal.
[19] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .
[20] E. Veys,et al. HL-A AND INFECTIVE SACROILEITIS , 1974 .
[21] W. Hacke,et al. Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN , 2016, International journal of stroke : official journal of the International Stroke Society.
[22] Harlan M Krumholz,et al. Increasing value and reducing waste: addressing inaccessible research , 2014, The Lancet.
[23] P. Sandercock,et al. Effect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality (Third International Stroke Trial) , 2014, Stroke.
[24] P. Sandercock,et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .